A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The phase III trial, which included adult patients…
Chemotherapy-free combination treatment outperforms traditional regimens in patients with Ph+ ALL
